Latest Schedule 13G passive stakes

CVI Investments, Inc. and Heights Capital Management, Inc. report combined beneficial ownership of 6.1% of Flag Ship Acquisition Corporation's ordinary shares as of December 31, 2025.

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed a Schedule 13G, reporting beneficial ownership of 6.4% of High-Trend International Group's Class A Ordinary Shares.

NXG Investment Management, operating as Cushing Asset Management, LP, has filed a Schedule 13G, reporting beneficial ownership of 300,000 shares, or 2.4%, of ARKO Petroleum Corp.'s Class A Common stock.

Menora Mivtachim Holdings Ltd. has reported beneficial ownership of 5.24% of Kenon Holdings Ltd. ordinary shares as of May 7, 2026.

Gem Investment Advisors, Gem Partners, Flat Rock Partners, and Daniel M. Lewis report combined 9.99% stake in ParkerVision Inc. as of March 31, 2026.

Brandon J. Olson has filed a Schedule 13G, reporting beneficial ownership of 6.6% of Black Rock Coffee Bar, Inc.'s Class A Common Stock.

Samuel W. Weatherford reports beneficial ownership of 539,732 shares, representing 2.5% of Class A Common Stock in Black Rock Coffee Bar, Inc.

MEITAV Investment House Ltd. and MEITAV Provident Funds & Pension Ltd. have reported beneficial ownership of over 5% of G Willi Food International Ltd.'s ordinary shares.

Liechtensteinische Landesbank Aktiengesellschaft and its subsidiary LLB Fund Services AG have reported beneficial ownership of 5.11% of Kelly Services Inc.'s Class A Common Stock.

The AES Corporation and AES Grid Stability, LLC have filed a Schedule 13G disclosing a 22.48% beneficial ownership stake in Fluence Energy, Inc.

The AES Corporation and AES Grid Stability, LLC have filed a Schedule 13G disclosing a 22.48% beneficial ownership stake in Fluence Energy, Inc.

Lynx1 Capital Management LP and Weston Nichols have disclosed a 17.4% beneficial ownership stake in GH Research PLC.

Lynx1 Capital Management LP has reported an 8.1% beneficial ownership stake in Stoke Therapeutics, Inc. as of March 31, 2026.

Whittier Trust Company and Whittier Holdings, Inc. have filed a Schedule 13G reporting a 9.83% beneficial ownership stake in Usio, Inc.

Fengrui Enterprise Limited and Dongdong Fang have filed a Schedule 13G reporting a 6.96% beneficial ownership stake in INLIF Ltd.

Herui Enterprise Limited and Xiurun Huang have filed a Schedule 13G reporting a 7.44% beneficial ownership stake in INLIF Limited.

Zhonghe Enterprise Limited and Siwen Dai have filed a Schedule 13G disclosing a 7.49% beneficial ownership stake in INLIF Ltd.

Jiutai Enterprise Limited and Hongxia Xu have filed a Schedule 13G disclosing a 7.53% beneficial ownership stake in INLIF Ltd.

Yongce Enterprise Limited and Zhaoyang Liu have filed a Schedule 13G reporting a 7.68% beneficial ownership stake in INLIF Ltd.

Tongyu Enterprise Limited and Jianlin Liu have filed a Schedule 13G disclosing a 7.77% beneficial ownership stake in INLIF Ltd.

Ance Enterprise Limited and Yunyang Huang have filed a Schedule 13G disclosing beneficial ownership of 8.73% of INLIF Ltd's Class A ordinary shares.

Zhongzheng Xu and Guangce Enterprise Limited have filed a Schedule 13G disclosing a 9.12% beneficial ownership stake in INLIF Ltd.

Changxin Enterprise Limited and Bingxian Xu have filed a Schedule 13G reporting a 9.6% beneficial ownership stake in INLIF Limited.

National Services, Inc. has filed an amendment to its Schedule 13G, reporting a 9.86% beneficial ownership stake in Usio, Inc. common stock.

Lightspeed Venture Partners XV-B (Ignite), L.P. has filed a Schedule 13G reporting a 7.6% beneficial ownership stake in Odyssey Therapeutics, Inc.

Divisadero Street Capital Management, LP has filed an amendment reporting a 13.8% beneficial ownership stake in Lifeway Foods, Inc.

Viking Global Investors LP and affiliated entities have reported a 5.4% beneficial ownership stake in Artiva Biotherapeutics, Inc. following a recent underwritten offering.

Millennium Management LLC and affiliated entities have reported a 6.1% beneficial ownership stake in Cytek Biosciences, Inc.

Point72 Asset Management and Steven A. Cohen have reported a 6.2% beneficial ownership stake in Sweetgreen, Inc. via a Schedule 13G filing.

Jonathan H. Dorfman filed an amendment to Schedule 13G reporting zero beneficial ownership of QVC Group, Inc. Series A Common Stock.